Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.

During the past decade, Rabin Medical Center-Beilinson Campus;Hematology-Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are "Leukemia, Myeloid, Acute" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials), "Malignant Melanoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" in a lesser frequency.

Most popular intervention types in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Obinutuzumab" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "89Zr-Df-IAB22M2C" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rabin Medical Center-Beilinson Campus;Hematology-Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rabin Medical Center-Beilinson Campus;Hematology-Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".